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Amphotericin  B (AmB)  is  a very  efﬁcient  drug  against  serious  diseases  such  as  leishmaniasis  and  systemic
fungal  infections.  However,  its  oral  bioavailability  is limited  due  to its  poor  solubility  in  water.  Neverthe-
less,  it is  marketed  as  high-cost  lipid  parenteral  formulations  that may  induce  serious  infusion-related
side  effects.  In  this  study,  oil-in-water  (O/W)  microemulsions  (MEs)  were  developed  and  characterized
with  a  view  to their  use  as  solubility  enhancers  and  oral  delivery  systems  for AmB.  Therefore,  different
nonionic  surfactants  from  the  Tween® and  Span® series  were  tested  for their  solubilization  capacity  inmphotericin B
ipids
icroemulsions
urfactants
heology
n vitro toxicity
combination  with  several  oils. Based  on  pseudoternary  phase  diagrams,  AmB-loaded  MEs  with  mean
droplet  sizes  about  120 nm  were  successfully  produced.  They  were  able  to improve  the  drug  solubility
up  to 1000-fold.  Rheological  studies  showed  the  MEs  to be  low-viscosity  formulations  with  Newtonian
behavior.  Circular  dichroism  and  absorption  spectra  revealed  that  part  of  the  AmB  in the  MEs  was  aggre-
gated  as an  AmB  reservoir  carrier.  Cytotoxicity  studies  revealed  limited  toxicity  to  macrophage-like  cells
that  may  allow  the formulations  to  be considered  as  suitable  carriers  for AmB.. Introduction
Amphotericin B (AmB) is a polyene antibiotic with potent anti-
ungal and leishmanicidal activities (Hartsel and Bolard, 1996;
brahim et al., 2012). Its chemical structure is characterized by
 glycosylated lactone with an amphiphilic polyhydroxyl region,
 conjugated heptane chromophore and an amphoteric ion pair
Fig. 1). As a consequence of both apolar and polar sides of its lac-
one ring and due to the presence of ionizable carboxyl and amine
roups, AmB  molecule presents both amphoteric and amphiphilic
ehavior (Damasceno et al., 2012). As a result, AmB  is poorly solu-
le in aqueous media and in many organic solvents (Torrado et al.,
008). This low solubility leads to limited bioavailability and mem-
rane permeability, which hinder the development of formulations
or the oral route that is the most convenient and acceptable route
or patients.
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On the other hand, effective lipid parenteral formulations of
AmB  have been developed and marketed, but they have some
serious limitations such as the inconvenience and complexity of
the intravenous administration, the incidence of serious acute
infusional side effects and the high cost that poses an impor-
tant barrier for patients in developing countries (Wasan et al.,
2009).
Recently, lipid-based formulations have been extensively inves-
tigated as a suitable approach to improve the bioavailability of
poorly soluble drugs after oral administration (Han et al., 2009).
When incorporated into these systems, the active molecule is
believed to remain in solution throughout its period in the gas-
trointestinal tract (Pouton, 2006). Additionally, the absorption of
the drug could be enhanced by the presence of lipids as a result of
stimulation of biliary and pancreatic secretions by the gallbladder,
an increase in the gastric residence time and others (Dahan and
Hoffman, 2008).
Since microemulsions (MEs) are able to incorporate a wide range
of drug molecules, increase their solubilization and bioavailability,
and reduce their toxicity, they are promising delivery systems for
oral administration of lipophilic molecules, such as AmB  (Fanun,
2012; Pestana et al., 2008). Therefore, the aim of this work was to
develop oil-in-water (O/W) MEs  based on long- and medium-chain
triglycerides in order to increase the solubility of AmB  and enable
its use by the oral route.
642 A.E. Silva et al. / International Journal of Pharmaceutics 454 (2013) 641– 648
e of AmB  (Santos et al., 2012).
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Table 1
Composition of the surfactant blends and their ﬁnal HLB values.
Surfactant blend Surfactants Weight ratio HLB
M1 Tween® 80 Span® 20 3:2 12.4
M2  Tween® 80 Span® 20 7:3 13.1
M3  Tween® 80 Span® 20 4:1 13.7
M4  Tween® 80 Span® 20 9:1 14.4
M5  Tween® 80 Span® 80 3:2 10.7
M6  Tween® 80 Span® 80 7:3 11.8
M7  Tween® 80 Span® 80 4:1 12.9
M8  Tween® 80 Span® 80 9:1 13.9
M9  Tween® 80 Span® 85 3:2 9.7
M10  Tween® 80 Span® 85 7:3 11.0
M11  Tween® 80 Span® 85 4:1 12.4
M12  Tween® 80 Span® 85 9:1 13.7
2.2.4. Preparation of microemulsions
Based on the pseudoternary phase diagrams, the most suit-
able ratios of oil, surfactant blend and water for the production of
O/W microemulsions were selected. The lipid was  mixed with the
Table 2
Classiﬁcation of the systems generated on the pseudoternary diagrams.
Category Description
Microemulsions (ME) Transparent or translucent and can ﬂow easily
Liquid crystal (LC) Transparent or translucent nonﬂowable when
inverted 90◦
Emulsion (EM) Milky or cloudy and can ﬂow easily
Emollient gel or cream Milky or cloudy non ﬂowable when invertedFig. 1. Chemical structur
. Materials and methods
.1. Materials
.1.1. Chemicals
Sodium hydroxide (NaOH), chloride acid (HCl), amphotericin
 (AmB) and HPLC grade methanol were purchased from
igma–Aldrich (Saint Quentin Fallavier, France).
.1.2. Surfactants
Span® 20, Span® 80, Span® 85, Tween® 20, Tween® 80 and
ween® 85 were purchased from Sigma–Aldrich (Saint Quentin
allavier, France).
.1.3. Lipids
Capryol® 90 (C90), Capryol® PGMC (CPGMC), Lauroglycol® 90
L90), Labrafac® lipophile WL  1349 (LWL), Labrafac® PG (LPG) and
eceol® (Pec) were kindly supplied by Gattefossé S.A. (Saint-Priest,
rance). Corn oil and olive oil were obtained from Sigma–Aldrich
Saint Quentin Fallavier, France).
.2. Methods
.2.1. Selection of oil and hydrophilic surfactant
Nonionic surfactants of the Tween® series (Tween® 20, 80 and
5) and the lipids mentioned in Section 2.1.3 were weighed and put
nto a series of screwcap test tubes in the ratios of 0.1:0.9, 0.2:0.8,
.3:0.7, 0.4:0.6, and 0.5:0.5 (w/w) g of 1 g per batch, mixed together,
nd vortexed thoroughly. Afterwards, 100 L of distilled water was
dded to each oil–surfactant mixture in 20–25 L drops using a
icropipette. After each drop of water was added, the system was
ortexed for 15 s at room temperature.
Visual observations were made, and the clarity or turbidity
f each sample was recorded. The isotropy of each system was
lso observed by light polarized microscopy through a Nikon E600
clipse direct microscope (Champigny/Marne, France) equipped
ith a long focus objective (LWD 40 × 0.55; 0–2 mm).  A Nikon
oolpix 950 camera was used to record the images with a resolution
f 1600 × 1200 pixels. The surfactant forming most clear systems
as selected as the hydrophilic surfactant that best matched the
ested lipid.
.2.2. Selection of surfactant blends
The individual nonionic hydrophilic surfactant chosen in Section.2.1 was blended with the lipophilic surfactants of the Span® series
Span® 20, 80 and 85) in ratios of 3:2, 7:3, 4:1, and 9:1 (w/w)  to
roduce blends of surfactants with various hydrophilic-lipophilic
alances (HLBs) in the range of 9.7–14.4 (Table 1). The solubilizationM,  mixture; HLB, hydrophilic LIPOPHILIC balance, mixture; HLB, hydrophilic
lipophilic balance.
capacities of the blends of surfactants were studied using the same
method as that used to study the other surfactants individually. The
blend of surfactants forming a clear system at most of the ratios was
selected as the blend that best matched the HLB of the tested lipid.
2.2.3. Construction of pseudoternary phase diagrams
After selection of the most suitable surfactant blend, pseu-
doternary phase diagrams were constructed based on the types of
systems formed when the mixtures of lipids and surfactant blend
were serially titrated by water followed by sonication. The systems
were characterized by visual observation as described by Mahdi
et al. (2011) (Table 2). The systems were also assessed regarding
their isotropy by polarized light microscopy as described in Section
2.2.1.(EG or EC) 90◦
Bicontinuous phase (BP) More than one type of dispersion existing in
the mixture, as indicated by the presence of
more than one abbreviation of dispersions
A.E. Silva et al. / International Journal of P
Table  3
Composition of the AmB-loaded and AmB-unloaded microemulsions.
Formulation Oil Oil:surfactant weight ratio AmB
ME  1 C90 1:9 −
ME  2 C90 2:8 −
ME  3 CPGMC 1:9 −
ME  4 CPGMC 2:8 −
ME-AmB 1 C90 1:9 +
ME-AmB 2 C90 2:8 +
ME-AmB 3 CPGMC 1:9 +
ME-AmB 4 CPGMC 2:8 +
The surfactant blend selected for all the formulations comprised a mixture of
Tween® 80:Span® 80 in the weight ratio of 9:1. ME  1, ME 2, ME  3 and ME 4 are
AmB-unloaded formulations while ME-AmB 1, ME-AmB 2, ME-AmB 3 and ME-AmB
4  are AmB-loaded formulations. All formulations have 83.3% of water, 1.7% of oil
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Qnd  15% of surfactant blend for ME  1, ME  3, ME-AmB 1 and ME-AmB 3, 3.4% of oil
nd 13.3% of surfactant blend for ME 2, ME 4, ME-AmB 2 and ME-AmB 4. The AmB
ontaining formulations have 0.08% of AmB.
urfactant blend in the weight ratios of 1:9 and 2:8 and 5 mL
f water (Table 3). The mixture was vortexed and subjected to
onication at 140 V for 60 s (Digital Soniﬁer, model 450, Branson
ltrasonic SA, France).
.2.5. Drug incorporation
An excess of AmB  was added to the blank MEs, and the systems
ere vortexed for 2 min. After stirring, the mixtures were left for 10,
0 and 60 min  under magnetic stirring at pH 11 in order to evaluate
he time necessary for the incorporation of AmB  into the systems
t 25 ± 0.1 ◦C. Thereafter, the pH was neutralized. The MEs  were
entrifuged at 10,000 × g in a Hitachi Himac CP-80 Ultracentrifuge
USA) for 15 min  to remove the excess of drug. The supernatant was
ecovered and carefully ﬁltered using a 0.22 m membrane. The
ltrate was diluted and dissolved in methanol for the quantitative
nalysis of the AmB by HPLC.
.2.6. Microemulsion characterization
.2.6.1. Droplet hydrodynamic size, distribution and morphology.
he droplet hydrodynamic size and distribution were evaluated
y dynamic light scattering (DLS) using a Malvern-Zetasizer Nano
S (Malvern, Worcestershire, UK). The morphology of the droplets
f selected O/W MEs  was observed by transmission electron
icroscopy (TEM) using an electron microscope JEOL 1400 (SamX-
lus, France) equipped with a high resolution CCD Gatan digital
amera (SC1000 Orius, France) and operated at 60 kV as the accel-
ration voltage.
.2.6.2. Quantitative analysis of AmB. The incorporation of AmB  was
etermined by high performance liquid chromatography (HPLC)
sing a Waters 2690 separations module, with a Waters 2487
ual absorbance detector (Waters, Guyancourt, France) and a
18 column (Interchim, 150 mm × 3 mm,  5 m).  The mobile phase
onsisted of a solution containing methanol/water (80:20). An iso-
ratic elution was performed with a ﬂow rate of 0.5 ml  min−1. UV
etection was performed at a wavelength of 406 nm and 25 L of
able 4
ualitative and quantitative composition and HLB values of the lipids tested as the oil ph
Lipid Composition 
Capryol® 90 Propylene glycol mono- and diesters of capry
Capryol® PGMC Propylene glycol mono- and diesters of capry
Lauroglycol® 90 Propylene glycol mono- and diesters of lauric
Labrafac® PG Dipropylene glycol esters of caprylic and capr
Labrafac® lipophile WL  1349 Triglycerides of caprylic and capric acids 
Peceol® Mono-, di- and triglycerides of oleic acid (C18
Corn  oil Triglycerides of linoleic acid (18:2) (60%), ole
Olive  oil Triglycerides of oleic acid (55–85%), linoleic aharmaceutics 454 (2013) 641– 648 643
sample was injected for each analysis. To determine the linear-
ity of the method, different concentrations of AmB  in the range
0.07–4 g mL−1 were prepared and analyzed.
2.2.6.3. Rheological behavior. The rheological properties of AmB-
loaded and unloaded MEs  were determined using a controlled-
stress ARG2 rheometer (TA instruments) with cone-plate geom-
etry. The cone-plate geometry is a 1◦ Peltier plate aluminum cone
with a 40 mm diameter and a truncation gap of 28 m between
the cone and plate. The analyses were carried out with a shear rate
in the range of 10−3–105 s−1. All rheological determinations were
carried out in triplicate for all samples and at 25.0 ± 0.2 ◦C.
2.2.6.4. Absorption and circular dichroism (CD). Absorbance mea-
surements were made by using a Perkin-Elmer Lambda 11 UV–vis
spectrophotometer. The CD spectra were recorded with a Jasco
J-810 dichrograph, and ∈  (M−1 cm−1) is the differential molar
absorption dichroic coefﬁcient. These spectroscopic measurements
were made at room temperature (around 20 ◦C) after dilution in
water to a ﬁnal AmB concentration of 0.3 mg/mL (path length of
quartz cuvette: 1 cm)  to evaluate the aggregation state of AmB  in
the formulations.
2.2.6.5. Toxicity of AmB-loaded microemulsions against macrophages.
The cytotoxicity of the AmB-loaded and unloaded MEs
was tested using the MTS  [3-(4,5-dimethyl-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium,
inner salt] assay. The conversion of this salt by mitochondrial
enzymes reﬂects the number of viable cells. J774.A1 cells (ECACC
catalog number 91051511) were cultivated in RPMI 1640 medium
supplemented with 10% heat-inactivated fetal calf serum (both
from Lonza Sales Ltd., Basel, Switzerland). For experiments, they
were seeded into 96-well plates at 5000 cells/well and incubated
for 24 h to allow adhesion. Samples of freshly prepared MEs
(50 L) were added to groups of 6 wells at the following AmB
concentrations: 1, 5, 10, 25, 50 and 100 g/mL. Wells without cells,
but containing the same concentration of unloaded MEs  were used
to estimate background absorbance due to light scattering. The
cells were incubated for 1 and 3 h at 37 ◦C and 0.5% CO2. Thereafter,
20 L of MTS  was added to the cells and they were incubated for
a further 2 h, after which the absorbance was measured using a
492-nm high-pass ﬁlter in a Multiskan MS  microwell plate reader
(Labsystem, Ramat-Gan, Israel). The mitochondrial enzymatic
activity was  expressed as a percentage of that of untreated control
cells, after correcting for background absorbance.
2.2.7. Statistical analysis
Statistical analysis of the raw data was conducted using one-
way analysis of variance (ANOVA) in Graph Pad Prism (Graph Pad
software for Mac  v. 6.0, San Diego, CA). Statistical signiﬁcance of dif-
ferences between two conditions was assessed using Tukey’s post
hoc method. Differences between different groups were considered
statistically signiﬁcant at p < 0.05.
ase.
HLB
lic acid (C8), the monoester fraction being predominant (>90%) 6
lic acid (C8), the monoester fraction being predominant (55–80%) 5
 acid (C12), the monoester fraction being predominant (>90%) 5
ic (C10) acids 2
1
:1), the monoester being predominant (32–52%) 3
ic acid and linoleic acid (18:3) (<15%). 9
cid (7.5–20%) and palmitic acid (C16:0) (7.5–20%) 8
6 al of Pharmaceutics 454 (2013) 641– 648
3
3
t
o
i
t
a
e
h
t
w
a
h
a
d
i
d
I
t
o
n
3
t
a
t
C
p
s
2
s
t
(
i
s
i
a
v
i
2
w
s
m
t
T
(
r
s
3
o
w
w
s
a
s
Fig. 2. Pseudoternary phase diagrams formed by (a) C90, (b) CPGMC and (c) L90 as44 A.E. Silva et al. / International Journ
. Results and discussion
.1. Selection of surfactant and surfactant blends
C90, CPGMC, L90, LPG, LWL  and Pec are liquid at room tempera-
ure and they are mainly composed of mono-, di- and triglycerides
f caprylic, capric, lauric and oleic acids. Their exact composition
s listed in Table 4, according to information from the supplier and
he literature (Varka and Karapantsios, 2011).
In order to develop MEs, an important parameter take into
ccount is the HLB of the surfactant or surfactant mixture (Feng
t al., 2009). It is related to the contribution of both hydrophilic and
ydrophobic fragments of a surfactant molecule. Generally, surfac-
ants with HLB values between 8 and 20 are able to form O/W MEs,
hile W/O  MEs  are formed when the HLB range is 4–7 (Lawrence
nd Rees, 2012).
Tween® 80 was shown to be the hydrophilic surfactant with the
ighest solubilization capacity when compared with Tween® 20
nd Tween® 85. These emulsiﬁers have the same polar head, but
ifferent hydrophobic tails (lauric, oleic and oleic acid, respectively
n Tween 20, 80 and 85). The length of these hydrophobic chains
etermines the interactions with the oil phase (Mosca et al., 2013).
n our experiments, we obtained clear mixtures of water and oil at
he highest weight ratios for C90, CPGMC and L90. For the other
ils tested, no clear mixture was obtained. Therefore, these were
ot used in further studies.
It is possible that the low HLBs of LPG, LWL  and Pec: 2, 1 and
 respectively, were responsible for the incompatibility between
hese lipids and the hydrophilic surfactants. Furthermore, the inter-
ctions between surfactants at an oil–water interphase are known
o be highly dependent on the nature of the oil (Mosca et al., 2013).
orn and olive oils are composed of long-chain triglycerides and
robably showed a weak interaction with the surfactant from the
ame fatty acid derivative, as stated in the literature (Mahdi et al.,
011).
It is known that a single surfactant is not sufﬁcient to form
ingle-phase microemulsions and an adequate mixture of surfac-
ants may  be required to optimize the microemulsion formation
Djekic et al., 2011). The use of mixtures of nonionic surfactants
s an interesting approach from the pharmaceutical point of view,
ince such surfactants are generally regarded as having low toxic-
ty and irritancy and therefore, considered to be acceptable for oral
dministration. Additionally, the use of mixtures allows the indi-
idual concentration of each surfactant to be decreased, which may
ncrease the biocompatibility of the ﬁnal formulations (Djekic et al.,
011; Pouton and Porter, 2008). Therefore, Tween® 80 was  mixed
ith the hydrophobic surfactants of the Span® series to provide
urfactant blends in order to screen and select the best surfactant
ixture to prepare oil-in-water microemulsions.
The results obtained for the solubilization power of the surfac-
ant blends revealed two mixtures as having the highest capacities:
ween® 80/Span® 20 7:3 (v/v) (M2) and Tween® 80/Span® 80 9:1
v/v) (M8), the HLB values of the two blends being 13.1 and 13.9,
espectively. Thus, these two surfactant blends were selected to
tudy the phase diagram behavior of C90, CPGMC and L90.
.2. Construction of pseudoternary phase diagrams
According to the pseudoternary phase diagrams, several types
f dispersions could be produced by mixing C90, CPGMC and L90
ith the surfactant blends M2 and M8  followed by titration with
ater. For instance, large areas of emulsions, microemulsions andome considerable areas of liquid crystal could be detected, as well
s smaller areas of bicontinuous phase, cream and gel (Figs. 2 and 3).
Both the surfactant blends M2  and M8 were able to produce
ome microemulsion-forming regions for the three lipids testedthe oil phase and Tween 80:Span 20 7:3 (w/w) as the surfactant blend and water. ME,
microemulsions; LC, liquid crystal; EM,  emulsion; EG, emollient gel; EC, emollient
cream; BP, bicontinous phase; PS, phase separation.
(Figs. 2 and 3). This seems to be coherent with the HLB values of
surfactants or mixture of surfactants reported to be optimal for the
preparation of microemulsions, since M2  and M8  presented very
similar HLB values: 13.1 and 13.9, respectively. However, it was  evi-
dent that both C90 and CPGMC were able to produce larger areas of
O/W emulsions and O/W microemulsions than L90. Thus, propylene
A.E. Silva et al. / International Journal of P
Fig. 3. Pseudoternary phase diagrams formed by (a) C90, (b) CPGMC and (c) L90
a
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ss  the oil phase and Tween® 80:Span® 80 9:1 (w/w) as the surfactant blend and
ater. ME,  microemulsions; LC, liquid crystal; EM,  emulsion; EG, emollient gel; EC,
mollient cream; BP, bicontinous phase; PS, phase separation.
lycol esters of caprylic acid seem to be more appropriate for the
reparation of O/W emulsions and microemulsions than propylene
lycol esters of lauric acid. Furthermore, the phase diagram behav-
or of those lipids was not only affected by the HLB value of the
urfactant, but also by the structure of the co-surfactant.
Previous studies have observed that in general the most stable
mulsions are formed when the two emulsifying agents have the
ame hydrocarbon chain length, such as the combination betweenharmaceutics 454 (2013) 641– 648 645
Tween® 80 and Span® 80, because of their similar chemical struc-
ture (Schmidts et al., 2009). Mahdi and coworkers stated that high
solubilization capacity can be obtained when surfactants with the
lowest and highest HLB values are mixed. In our case, we believe
that the three chains of oleic acid esters in the molecule of Span®
85 hinder the interaction with Tween® 80. On the other hand, the
interaction between Span® 80 and Tween® 80 proved to be more
effective in reducing the oil-water interfacial tension and producing
MEs. These formulations were used for further studies.
3.3. Microemulsion characterization
Regardless of the oil phase, DLS and TEM analysis revealed
that drug-free and drug-loaded MEs  were composed of spherical
non-aggregated droplets with mean sizes around 80 and 120 nm
respectively (Fig. 4). This increase in the diameter of the ME  droplets
after the incorporation of AmB  is explained by the fact that AmB  has
surface properties due to its amphiphilic behavior and is adsorbed
at the oil-water interface (Franzini et al., 2012; Santos et al., 2012).
The polydispersity index was shown to be around 0.25 and 0.31 for
unloaded MEs  and AmB-loaded MEs, respectively.
When the quantity of encapsulated AmB by was measured by
HPLC, it was  shown that the drug incorporation was dependent on
the volume fraction of the dispersed phase and ranged between
70% and 90%. These data highlight the fact that the MEs  are able to
increase the AmB  solubility up to 1000-fold when compared with
its solubility in water. It also gives further evidence for the strong
interaction between the hydrophobic AmB  molecule and the oil
present in the ME  (Franzini et al., 2012). More precisely, the ME  con-
taining C90 as the oil phase at the weight ratio of 2:8 (oil:surfactant)
gave the highest rate of incorporation of AmB. The incorporation
time did not inﬂuence the amount of AmB  incorporated, showing
that the association occurred rapidly over 10 min.
3.4. Rheological behavior
The physicochemical characterization of delivery systems is
an essential step in the pre-formulation process to predict the
feasibility of the ﬁnal products. Among the parameters for the
characterization of MEs, rheology is a fundamental approach to
investigate structural properties and acquire helpful information
not only on the stability of such systems, but also on the handling,
storage and pipeline transportation of MEs  (Formariz et al., 2010;
Pal, 2011).
Although the rheological analysis indicated that the viscosity
was very low for all the samples, it appeared to decrease at low
shear rates between 10−3 and 10 s−1 and remained constant at
higher shear rates than 10 s−1 (data not shown). However, the ﬂow
curves revealed that all the ME  systems showed a linear relation-
ship between the shear stress and shear rate, which is a feature
of Newtonian ﬂow materials (Feng et al., 2009) (Fig. 5a and b).
These results conﬁrm that our samples are discontinuous MEs.
As reported by previous studies, discontinuous MEs  show con-
stant viscosity over a wider range of shear rates than bicontinuous
MEs  (Acharya and Hartley, 2012). As a consequence of their low
viscosity, such systems are considered suitable for oral delivery
(Lawrence and Rees, 2012).
The inﬂuence of AmB  on the micro-organization of the MEs  was
investigated. No change in the linear proﬁle of the ﬂow curves was
observed (Fig. 5b), indicating that the drug did not inﬂuence the
ﬂow properties of the system.3.5. Aggregate state of AmB
AmB  self-associates in aqueous media, forming supramolecu-
lar aggregates. Monomers, and soluble and insoluble aggregates
646 A.E. Silva et al. / International Journal of Pharmaceutics 454 (2013) 641– 648
Fig. 4. TEM images of AmB-loaded microemulsions based on C90:M8 at 1:9 (a) and 2:8 (b
30,000×  and 15,000×, respectively.
Fig. 5. Flow curves of (a) AmB-loaded and (b) AmB-unloaded MEs.) (w/w), and CPGMC at 1:9 (c) and 2:8 (d) (w/w), at magniﬁcation of 4000×, 2500×,
present in the dispersing medium determine the toxicity of AmB
(Gaboriau et al., 1997; Silva-Filho et al., 2012). In order to study
the aggregation state of AmB  molecules after incorporation into
the MEs, the formulations were analyzed by circular dichroism and
electronic absorption. These methods are useful and sensitive tools
to identify changes in the conformation of AmB  (Bolard et al., 1981).
The presence of 7 conjugated double bonds in this molecule leads to
very characteristic spectra between 300 and 450 nm, which depend
on conformational changes as a result of its self-association in water
or its association with other compounds, such as lipids (Boudet and
Bolard, 1979; Espuelas et al., 1998). These distinctive optical prop-
erties of AmB  enable its study by both electronic absorption and
circular dichroism spectroscopy (Barwicz et al., 2002; Boudet and
Bolard, 1979).
As can be seen in Fig. 6a, the absorption spectrum of a stock solu-
tion of AmB  in methanol after dilution in water to 0.3 mg/mL shows
three bands at 410, which are characteristic of the monomeric form,
385, 365 nm and a smaller band at 344 nm.  The absorption spectra
for the MEs  at the same concentration of AmB  showed peaks at the
same wavelengths, but with different intensities (Fig. 6a).
In addition, a peak at 318 nm was detected at different intensi-
ties for each formulation. This is believed to indicate the presence of
self-associated molecules of AmB. Thus, a part of the AmB  in the MEs
was shown to be aggregated. The formulation containing CPGMC
as the oil phase at the weight ratio of 1:9 (ME-AmB 3) between oil
to surfactant mixture showed the lowest proportion of aggregates
and the highest proportion of monomers. Its spectrum appears to
be very similar to that of AmB  in methanol (Fig. 6a).
These results are corroborated by the CD spectra of the MEs
(Fig. 6b). They reveal the dichroic doublet, which is characteris-
tic of the aggregation state of AmB, for all the formulations with
the center at 317 nm,  with different intensities depending on the
system. It is important to note that the CD spectra of AmB in water
and in methanol are completely different (Fig. 6c), with the lat-
ter one showing no dichroic doublet, which is characteristic of the
monomer state of AmB.
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Fig. 7. Dose–response effects of AmB-unloaded and AmB-loaded MEs  containing
C90  as the oil phase in the weight ratio of 2:8 (oil:surfactant) (ME  2 and ME-AmB 2,
respectively) and a solution of AmB in DMSO as a control (AmB-DMSO) on the cyto-ig. 6. (a) Electronic absorption and (b) CD spectra of an aqueous solution of AmB-
oaded MEs  and (c) CD spectra of an aqueous solution and a methanolic solution of
mB  (insert: CD spectrum in methanol with an expanded ordinate).
.6. Cytotoxicity proﬁle
Fig. 7a and b show the viability of J774 macrophages as deter-
ined by MTS  conversion after contact with AmB-unloaded ME
ME  2), AmB-loaded ME  (ME-AmB 2) and a solution of AmB  in
MSO (AmB-DMSO) for 1 h and 3 h, respectively. The chosen for-
ulation corresponds to the ME  with C90 as the oil phase and 2:8 as
he weight ratio between C90 and the surfactant mixture Tween®
0:Span® 80 (9:1) (w/w) (M4  on Table 1).toxicity on mouse macrophages (J774 cell line) after (a) 1 h and (b) 3 h of incubation,
in the MTS  conversion assay. Results are presented as a percentage of the activity of
untreated cells.
As can be seen in Fig. 7a, the cell viability exceeded 80% after
1 h for the concentrations 1, 5 and 10 g/mL, but fell to about 60%
when the AmB  concentration increased to 25 g/mL, or when the
equivalent amount of unloaded MEs  were added. This suggests that
both blank and drug-loaded ME  may  be considered as having low
acute toxicity probably induced by the volume of ME added to the
medium, 50 L, which contains a large amount of Tween® 80. On
the other hand, after 3 h incubation the cell viability remained high
at approximately 85% for the AmB concentrations of 1 and 5 g/mL
while the blank ME  and drug-loaded ME  exhibited slightly higher
toxic effects at higher concentrations of AmB. However, the formu-
lations appeared to affect cell viability less than a solution of AmB
in DMSO at the same concentration (Fig. 7b). Similar results were
obtained for the other three ME  formulations (not shown).
The MTS  assay revealed that the cytotoxicity of the MEs  was
time-dependent. There is an indication that the MEs reduce the
cytotoxicity at low concentrations, although at AmB  concentrations
higher than 25 g/mL no advantage of the MEs  could be observed.
Regardless of the time of contact between the formulations and the
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acrophages, statistical analysis showed no signiﬁcant differences
or the low concentrations of AmB  (1 and 5 g/mL) and the equiva-
ent unloaded MEs, but they were signiﬁcant for the concentrations
f 10 and 25 g/mL and their corresponding unloaded MEs.
. Conclusions
Our results demonstrate that it is important to select surfactants
nd mixtures of surfactants with not only a suitable HLB value, but
lso with structural similarity with the chosen oil phase for success-
ul ME  formulation. The best surfactant mixture to provide O/W ME
ith medium chain triglycerides based on caprylic esters as the oil
hase was shown to have HLB value around 13. More precisely,
ween® 80:Span® 80 in the weight ratio of 9:1 was the surfactant
roviding greater solubilization capacity for C90 and CPGMC. They
lso improved the solubility of AmB  up to 1000-fold and showed
uitable rheological behavior for the oral administration. However,
tudies of electron absorption and CD spectra revealed the pres-
nce of aggregates of AmB. They are likely to be at the origin of
he time-dependent cytotoxicity of our formulations, which were
lightly less toxic than a solution of AmB  in DMSO, although all for-
ulations were well supported by J774 cells at concentrations up
o 25 g/mL of AmB.
cknowledgments
The authors wish to thank Dr. Claire Gueutin for the support
ith HPLC analysis and Dr. Nicolas Huang and Sarah Mosbah for
he rheological assays. This work was ﬁnancially supported by
APES/COFECUB.
eferences
charya, D.P., Hartley, P.G., 2012. Progress in microemulsion characterization. Curr.
Opin. Colloid Interface Sci. 17, 274–280.
arwicz, J., Beauregard, M., Tancrède, P., 2002. Circular dichroism study of inter-
actions of Fungizone or AmBisome forms of amphotericin B with human low
density lipoproteins. Biopolymers 67, 49–55.
olard, J., Vertut-Croquin, A., Cybulska, B.E., Gary-Bobo, C.M., 1981. Transfer of the
polyene antibiotic amphotericin B between single-walled vesicles of dipalmi-
toylphosphatidylcholine and egg-yolk phosphatidylcholine. Biochim. Biophys.
Acta Biomembr. 647, 241–248.
oudet, G., Bolard, J., 1979. Interaction of the polyene antibiotic amphotericin B with
phospholipid bilayer membranes: a circular dichroism study. Biochem. Biophys.
Res. Commun. 88, 998–1002.
ahan, A., Hoffman, A., 2008. Rationalizing the selection of oral lipid based drug
delivery systems by an in vitro dynamic lipolysis model for improved oral
bioavailability of poorly water soluble drugs. J. Control. Release 129, 1–10.
amasceno, B.P.G.L., Dominici, V.A., Urbano, I.A., Silva, J.A., Araújo, I.B., Santos-
Magalhães, N.S., Silva, A.K.A., Medeiros, A.C., Oliveira, A.G., Egito, E.S.T., 2012.
Amphotericin B microemulsion reduces toxicity and maintains the efﬁcacy as
an  antifungal product. J. Biomed. Nanotechnol. 8, 290–300.
jekic, L., Primorac, M.,  Jockovic, J., 2011. Phase behaviour, microstructure and
ibuprofen solubilization capacity of pseudo-ternary nonionic microemulsions.
J.  Mol. Liq. 160, 81–87.
spuelas, M.S., Legrand, P., Cheron, M.,  Barratt, G., Puisieux, F., Devissaguet, J.P.,
Irache, J.M., 1998. Interaction of amphotericin B with polymeric colloids: a
spectroscopic study. Colloids Surf. B Biointerfaces 11, 141–151.harmaceutics 454 (2013) 641– 648
Fanun, M., 2012. Microemulsions as delivery systems. Curr. Opin. Colloid Interface
Sci.  17, 306–313.
Feng, J.-L., Wang, Z.-W., Zhang, J., Wang, Z.-N., Liu, F., 2009. Study on food-grade
vitamin E microemulsions based on nonionic emulsiﬁers. Colloids Surf. A Physic-
ochem. Eng. Aspects 339, 1–6.
Formariz, T.P., Chiavacci, L.A., Scarpa, M.V., Silva-Junior, A.A., Egito, E.S.T., Terrugi,
C.H.B., Franzini, C.M., Sarmento, V.H.V., Oliveira, A.G., 2010. Structure and vis-
coelastic behavior of pharmaceutical biocompatible anionic microemulsions
containing the antitumoral drug compound doxorubicin. Colloids Surf. B Bioin-
terfaces 77, 47–53.
Franzini, C.M., Pestana, K.C., Molina, E.F., Scarpa, M.V., do Egito, E.S.T., de Oliveira,
A.G., 2012. Structural properties induced by the composition of biocompatible
phospholipid-based microemulsion and amphotericin B association. J. Biomed.
Nanotechnol. 8, 350–359.
Gaboriau, F., Chéron, M.,  Leroy, L., Bolard, J., 1997. Physico-chemical properties
of  the heat-induced superaggregates of amphotericin B. Biophys. Chem. 66,
1–12.
Han, S.-f., Yao, T.-t., Zhang, X.-x., Gan, L., Zhu, C., Yu, H.-z., Gan, Y., 2009. Lipid-based
formulations to enhance oral bioavailability of the poorly water-soluble drug
anethol trithione: effects of lipid composition and formulation. Int. J. Nanomed.
379, 18–24.
Hartsel, S., Bolard, J., 1996. Amphotericin B: new life for an old drug. Trends Pharma-
col. Sci. 17, 445–449.
Ibrahim, F., Gershkovich, P., Sivak, O., Wasan, E.K., Bartlett, K., Wasan, K.M., 2012.
Efﬁcacy and toxicity of a tropically stable lipid-based formulation of ampho-
tericin B (iCo-010) in a rat model of invasive candidiasis. Int. J. Pharm. 436,
318–323.
Lawrence, M.J., Rees, G.D., 2012. Microemulsion-based media as novel drug delivery
systems. Adv. Drug Deliv. Rev. 64, 175–193 (supplement).
Mahdi, E.S., Sakeena, M.H.F., Abdulkarim, M.F., Abdullah, G.Z., Sattar, M.A., Noor,
A.M., 2011. Effect of surfactant and surfactant blends on pseudoternary phase
diagram behavior of newly synthesized palm kernel oil esters. Drug Des. Dev.
Ther. 5, 311–323.
Mosca, M.,  Cuomo, F., Lopez, F., Ceglie, A., 2013. Role of emulsiﬁer layer, antioxidants
and radical initiators in the oxidation of olive oil-in-water emulsions. Food Res.
Int. 50, 377–383.
Pal, R., 2011. Rheology of simple and multiple emulsions. Curr. Opin. Colloid Inter-
face Sci. 16, 41–60.
Pestana, K.C., Formariz, T.P., Franzini, C.M., Sarmento, V.H.V., Chiavacci, L.A., Scarpa,
M.V., Egito, E.S.T., Oliveira, A.G., 2008. Oil-in-water lecithin-based microemul-
sions as a potential delivery system for amphotericin B. Colloids Surf. B
Biointerfaces 66, 253–259.
Pouton, C.W., 2006. Formulation of poorly water-soluble drugs for oral admin-
istration: physicochemical and physiological issues and the lipid formulation
classiﬁcation system. Eur. J. Pharm. Sci. 29, 278–287.
Pouton, C.W., Porter, C.J.H., 2008. Formulation of lipid-based delivery systems for
oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 60,
625–637.
Santos, C.M., Oliveira, R.B., Arantes, V.T., Caldeira, L.R., Oliveira, M.C., Egito, E.S.T.,
Ferreira, L.A.M., 2012. Amphotericin B-loaded nanocarriers for topical treatment
of  cutaneous leishmaniasis: development, characterization, and in vitro skin
permeation studies. J. Biomed. Nanotechnol. 8, 322–329.
Schmidts, T., Dobler, D., Nissing, C., Runkel, F., 2009. Inﬂuence of hydrophilic sur-
factants on the properties of multiple W/O/W emulsions. J. Colloid Interface Sci.
338, 184–192.
Silva-Filho, M.A., Siqueira, S.D., Freire, L.B., Araújo, I.B., Silva, K.G.H., Medeiros, A.C.,
Araújo-Filho, I., Oliveira, A.G., Egito, E.S.T., 2012. How can micelle systems be
rebuilt by a heating process? Int. J. Nanomed. 7, 141–150.
Torrado, J.J., Espada, R., Ballesteros, M.P., Torrado-Santiago, S., 2008. Amphotericin
B  formulations and drug targeting. J. Pharm. Sci. 97, 2405–2425.
Varka, E.M., Karapantsios, T.D., 2011. Global versus local dynamics during destabi-
lization of eco-friendly cosmetic emulsions. Colloids Surf. A Physicochem. Eng.
Aspects 391, 195–200.Wasan, E.K., Bartlett, K., Gershkovich, P., Sivak, O., Banno, B., Wong, Z., Gagnon, J.,
Gates, B., Leon, C.G., Wasan, K.M., 2009. Development and characterization of
oral lipid-based amphotericin B formulations with enhanced drug solubility,
stability and antifungal activity in rats infected with Aspergillus fumigatus or
Candida albicans. Int. J. Pharm. 372, 76–84.
